Global Connected Diagnostics Market Size, Share, and COVID-19 Impact Analysis, By Type (On-Premise and Cloud-Based), By Application (Clinical Research Organizations (CROs), Clinics, Hospitals, and Others), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2025 - 2035
Industry: HealthcareGlobal Connected Diagnostics Market Insights Forecasts To 2035
- The Global Connected Diagnostics Market Size Was Estimated at USD 9.19 Billion in 2024
- The Market Size is Expected to Grow at a CAGR of around 12.23% from 2025 to 2035
- The Worldwide Connected Diagnostics Market Size is Expected to Reach USD 32.70 Billion by 2035
- Asia Pacific is expected to grow the fastest during the forecast period.
Get more details on this report -
According to a research report published by Spherical Insights and Consulting, The Global Connected Diagnostics Market Size was worth around USD 9.19 Billion in 2024 and is Predicted To Grow to around USD 32.70 Billion by 2035 with a compound annual growth rate (CAGR) of 12.23 % from 2025 to 2035. The market for connected diagnostics offers opportunities due to developments in artificial intelligence and the Internet of Things, growth in developing nations, the rising need for individualized treatment, and the wider use of telemedicine and remote monitoring tools in international healthcare systems.
Global Connected Diagnostics Market Forecast and Revenue Outlook
- 2024 Market Size: USD 9.19 Billion
- 2035 Projected Market Size: USD 32.70 Billion
- CAGR (2025-2035): 12.23%
- North America: Largest market in 2024
- Asia Pacific: Fastest growing market
Market Overview
The healthcare and technology sector's segment devoted to combining diagnostic equipment with digital connectivity solutions to provide real-time data gathering, analysis, and transfer is known as the "connected diagnostics market." The connected diagnostics market includes platforms and systems that connect cloud-based infrastructure, electronic health records (EHRs), and telemedicine services with diagnostic tools such as imaging equipment, point-of-care devices, and laboratory instruments. By utilizing Internet of Things (IoT) technologies, wireless connectivity, and interoperability standards, connected diagnostics enable ongoing health monitoring, early disease identification, and better patient management. Technology breakthroughs, rising healthcare digitization, and a growing focus on personalized medicine are all driving the fast expansion of the global connected diagnostics market. Technological developments in medical devices, the creation of advanced data analytics tools, and the growing integration of linked devices within healthcare ecosystems are driving the connected diagnostics market's growth. The need for remote patient monitoring and early detection capabilities is fueled by the rising incidence of chronic diseases, including diabetes and cardiovascular problems, which propels the connected diagnostics market.
Key Market Insights
- North America is expected to account for the largest share in the connected diagnostics market during the forecast period.
- In terms of type, the cloud-based segment is projected to lead the connected diagnostics market throughout the forecast period
- In terms of application, the hospitals segment captured the largest portion of the market
Connected Diagnostics Market Trends
- Improving the precision, speed, and predictive power of diagnosis through the integration of artificial intelligence (AI).
- Increased need for quick, remote, and at-home diagnostics has led to the growth of point-of-care testing, or POCT.
- Internet of Things (IoT) expansion: IoT-enabled diagnostic tools for monitoring and transmitting health data in real time.
- Cloud-based platforms are being adopted: safe cloud infrastructure for sharing, storing, and evaluating diagnostic data.
- Growth of Virtual Care and Telehealth Services: Telemedicine incorporates diagnostics for smooth patient assessment.
Report Coverage
This research report categorizes the connected diagnostics market based on various segments and regions, forecasts revenue growth, and analyzes trends in each submarket. The report analyzes the key growth drivers, opportunities, and challenges influencing the connected diagnostics market. Recent market developments and competitive strategies, such as expansion, type launch, development, partnership, merger, and acquisition, have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyzes their core competencies in each sub-segment of the connected diagnostics market.
Global Connected Diagnostics Market Report Coverage
Report Coverage | Details |
---|---|
Base Year: | 2024 |
Market Size in 2024: | USD 9.19 Billion |
Forecast Period: | 2025-2035 |
Forecast Period CAGR 2025-2035 : | 12.23% |
2035 Value Projection: | USD 32.70 Billion |
Historical Data for: | 2020-2023 |
No. of Pages: | 235 |
Tables, Charts & Figures: | 110 |
Segments covered: | By Type, By Application, By Region |
Companies covered:: | Abbott, Siemens, Danaher, Roche Diagnostics, Philips Healthcare, Johnson & Johnson, Sysmex Corporation, Thermo Fisher Scientific, Becton Dickinson and Company, Others, and |
Pitfalls & Challenges: | COVID-19 Empact, Challenge, Future, Growth, & Analysis. |
Get more details on this report -
Driving factors
The growing need for real-time, data-driven healthcare solutions and the development of digital health technologies are the main factors driving the connected diagnostics market. The use of connected diagnostic systems is accelerating due to the rising prevalence of chronic diseases and the global shift toward personalized and preventative treatment. Furthermore, the demand for decentralized and networked diagnostic equipment is fueled by the expanding usage of telemedicine and home-based care models. Increased public and private sector investment, together with government measures supporting the transformation of digital health, further propels connected diagnostics market expansion.
Restraining Factor
The market for connected diagnostics is restricted by factors like high implementation costs, cybersecurity and data privacy issues, limited system interoperability, and regulatory complexity. These challenges work together to prevent widespread adoption, especially in areas with weak digital infrastructure and low resource availability.
Market Segmentation
The global connected diagnostics market is divided into type and application.
Global Connected Diagnostics Market, By Type:
- The cloud-based segment dominated the market in 2024 and is projected to grow at a substantial CAGR during the forecast period.
Based on type, the global connected diagnostics market is segmented into on-premise and cloud-based. Among these, the cloud-based segment dominated the market in 2024 and is projected to grow at a substantial CAGR during the forecast period. Cloud platforms' scalability, cost-effectiveness, deployment simplicity, and remote accessibility are the main factors driving the cloud-based market. Real-time data sharing, remote consultations, and enhanced interoperability between labs and healthcare providers are all made possible by cloud-based diagnostics solutions.
The on-premise segment in the connected diagnostics market is expected to grow at the fastest CAGR over the forecast period. Increased worries about data security, adherence to strict legal standards, and institutional preferences for internal data governance are the main factors driving the on-premise category. On-premise implementation is frequently preferred by healthcare businesses with legacy systems and sensitive patient data because it offers more customization and control.
Global Connected Diagnostics Market, By Application:
- The hospitals segment accounted for the largest share in 2024 and is anticipated to grow at a significant CAGR during the forecast period.
Based on application, the global connected diagnostics market is segmented into clinical research organizations (CROs), clinics, hospitals, and others. Among these, the hospitals segment accounted for the largest share in 2024 and is anticipated to grow at a significant CAGR during the forecast period. The extensive use of cutting-edge diagnostic technology by hospitals to handle high patient volumes, monitor chronic diseases, and integrate linked diagnostic tools to improve clinical workflows and patient outcomes is the reason for the hospital segment. The market is being driven by hospitals' growing adoption of connected diagnostics to enable real-time monitoring, increase diagnostic accuracy, and enable remote consultations.
Get more details on this report -
The clinical research organizations segment in the connected diagnostics market is expected to grow at the fastest CAGR over the forecast period. Growing investments in clinical trials, the requirement for real-time data collecting and analysis, and the growing usage of linked diagnostics to improve trial efficiency and data accuracy are driving the expansion of the clinical research organizations (CROs) market.
Regional Segment Analysis of the Global Connected Diagnostics Market
- North America (U.S., Canada, Mexico)
- Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
- Asia-Pacific (China, Japan, India, Rest of APAC)
- South America (Brazil and the Rest of South America)
- The Middle East and Africa (UAE, South Africa, Rest of MEA)
North America Connected Diagnostics Market Trends
North America is expected to hold the largest share of the global connected diagnostics market over the forecast period.
The North American region's high healthcare costs, early adoption of cutting-edge technologies, and established healthcare infrastructure are the reasons behind this. The majority of this growth is driven by the US in particular. Interoperable patient-centric apps for real-time diagnostics are promoted by government initiatives, like as the Trump Administration's July 2025 Health Tech Ecosystem Initiative with CMS and more than 60 tech companies. Strong internet access, extensive use of electronic health records (EHRs), and rising expenditures in AI and Internet of Things (IoT)-enabled diagnostic technologies all benefit the area.
U.S Connected Diagnostics Market Trends
The United States is distinguished by its early acceptance of novel medical solutions and its highly developed healthcare system. The market's growth is further accelerated by the existence of significant healthcare technology businesses as well as favorable legislative and regulatory frameworks. Furthermore, the United States' leadership in connected diagnostics innovation and deployment is strengthened by rising investments in AI, IoT, and cloud computing in healthcare diagnostics.
Canada Connected Diagnostics Market Trends
Canada's connected diagnostics industry is being pushed by rising expenditures in digital health technology and a focus on enhancing the effectiveness and accessibility of healthcare. The development of the sector is greatly aided by the Canadian government's sponsorship of health IT infrastructure as well as programs that encourage telemedicine and remote diagnostics.
Asia Pacific Connected Diagnostics Market Trends
Asia Pacific is expected to grow at the fastest CAGR in the connected diagnostics market during the forecast period.
The Asia-Pacific region as a result of growing access to healthcare technologies, increased chronic illness prevalence, and rising healthcare spending. The need for effective and affordable diagnostic solutions is growing throughout the region due to the rising incidence of chronic illnesses, growing middle-class populations, and rising healthcare costs. The adoption of telemedicine, the integration of smart diagnostic technologies, and digital health initiatives are being aggressively promoted by governments in nations like China, India, and Japan.
China Connected Diagnostics Market Trends
China's quick progress in digital healthcare, robust government support, and growing investment in medical technology innovation are its main drivers. The creation of intelligent healthcare infrastructure, as well as the use of telemedicine and remote diagnostics, are key components of the Chinese government's strategic objectives, such as the "Healthy China 2030" plan.
India Connected Diagnostics Market Trends
India's healthcare system is becoming more digitally advanced, chronic disease rates are rising, and preventative treatment is becoming more and more important. In order to facilitate the integration of connected diagnostic solutions, government programs like the Ayushman Bharat Digital Mission are encouraging the use of health IT infrastructure and interoperability standards.
Competitive Analysis:
The report offers the appropriate analysis of the key organizations/companies involved within the global connected diagnostics market, along with a comparative evaluation primarily based on their type of offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborate analysis focusing on the current news and developments of the companies, which includes type development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.
Worldwide Top Key Players In The Connected Diagnostics Market Include
- Abbott
- Siemens
- Danaher
- Roche Diagnostics
- Philips Healthcare
- Johnson & Johnson
- Sysmex Corporation
- Thermo Fisher Scientific
- Becton Dickinson and Company
- Others
Key Target Audience
- Market Players
- Investors
- End-users
- Government Authorities
- Consulting And Research Firm
- Venture capitalists
- Value-Added Resellers (VARs)
Recent development
- In January 2023, QIAGEN announced the EZ2 Connect MDx for use in diagnostic labs, eighteen months after the IVD platform for automated sample processing was made accessible for research.
- In July 2022, AACC Annual Scientific Meeting and Clinical Lab Expo, BrightInsight, Inc., the industry leader in biopharma and medtech regulated digital health solutions, today announced the debut of its digital Connected Diagnostics Platform. For manufacturers of in vitro diagnostics, an all-inclusive, end-to-end platform is a one-stop shop that optimizes processes, boosts revenue growth, and stimulates innovation.
Market Segment
This study forecasts revenue at the global, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the connected diagnostics market based on the following segments:
Global Connected Diagnostics Market, By Type
- On-Premise
- Cloud-Based
Global Connected Diagnostics Market, By Application
- Clinical Research Organizations (CROs)
- Clinics
- Hospitals
- Others
Global Connected Diagnostics Market, By Regional Analysis
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia Pacific
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- UAE
- Saudi Arabia
- Qatar
- South Africa
- Rest of the Middle East & Africa
Frequently Asked Questions (FAQ)
-
1. What is the CAGR of the connected diagnostics market over the forecast period?The global connected diagnostics market is projected to expand at a CAGR of 12.23% during the forecast period.
-
2. What is the market size of the connected diagnostics market?The global connected diagnostics market size is expected to grow from USD 9.19 billion in 2024 to USD 32.70 billion by 2035, at a CAGR 12.23% of during the forecast period 2025-2035.
-
3. Which region holds the largest share of the connected diagnostics market?North America is anticipated to hold the largest share of the connected diagnostics market over the predicted timeframe.
-
4. Who are the top companies operating in the global connected diagnostics market?Abbott, Siemens, Danaher, Roche Diagnostics, Philips Healthcare, Johnson & Johnson
-
5. What factors are driving the growth of the connected diagnostics market?Rising rates of chronic diseases, improvements in AI and IoT technologies, a rise in the use of telemedicine, government assistance, and the growing need for individualized, real-time healthcare solutions are some of the major reasons driving the growth of the connected diagnostics market.
-
6. What are market trends in the connected diagnostics market?Increasing telehealth applications, expanding point-of-care testing, enhancing interoperability, integrating AI and cloud computing, putting more focus on data security, and expanding usage in emerging economies with better digital infrastructure are some of the industry trends.
-
7. What are the main challenges restricting wider adoption of the connected diagnostics market?High implementation costs, worries about cybersecurity and data privacy, a lack of system interoperability, complicated regulations, and infrastructural constraints in remote and low-resource areas are the primary barriers to market.
Need help to buy this report?